SARS-CoV-2: Information and impacts
DOI:
https://doi.org/10.33448/rsd-v10i7.16767Keywords:
SARS-CoV-2; COVID-19; Novel coronavirus 2019; Social impact.Abstract
In Wuhan, China, at the end of 2019 there was an outbreak of viral pneumonia of unknown cause, until on January 7, 2020, the etiologic agent of this disease was identified by the Chinese Center for Disease Control and Prevention (CDC) in that it was a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) known as coronavirus 19 (COVID-19). Until June 1, 2021, this virus has infected around 170,814,464 people, causing 3,551,884 people to die, in addition to generating a series of social and economic problems in the world. Thus, this study aimed to document information regarding SARS-CoV-2 contained in the scientific literature, as well as the impacts generated on society by the new coronavirus. Searches were performed in the following databases: PubMed/MEDLINE, SciELO, and BVS using a search filter for articles from December 2019 to May 2021, which are the months that comprise studies related to SARS-CoV-2. Bibliographic searches were performed in May 2021 using the descriptors "COVID-19 and Impacts", "COVID-19 and Information", "Complication and COVID-19", and "COVID-19 and Fake News". Only findings in the English language (American and British) were taken into consideration. Thus, we hope that this study reinforces readers' knowledge with information about COVID-19 and its impacts on society. It also aims to measure and identify the vast scientific material that we already have available in the literature.
References
Araújo, J. L., Sousa, L. A. D., Sousa, A. O., Bastos, R. S., Santos, G. T., Lage, M. R., & Rocha, J. A. (2021). DFT, molecular docking, and ADME/Tox screening investigations of market‑available drugs against SARS‑CoV‑2. Journal of the Brazilian Chemical Society, 00(00), 1-14. https://dx.doi.org/10.21577/0103-5053.20210061
Bassetti, M., Vena, A., & Giacobbe, D. R. (2020). The novel Chinese coronavirus (2019‐nCoV) infections: Challenges for fighting the storm. European Journal of Clinical Investigation, 50(3), e13209. https://doi.org/10.1111/eci.13209
Brasil. LEI Nº 13.979, de 6 de fevereiro de 2020. Secretaria-Geral Subchefia para Assuntos Jurídicos. 2020. http://www.planalto.gov.br/ccivil_03/_ato2019-2022/2020/lei/L13979.htm/.
Canada. (2021). Drugs and vaccines for COVID-19. Canada.ca. https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/about.html.
Cui, J., Li, F., & Shi, Z. L. (2019). Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology, 17(3), 181-192. https://doi.org/10.1038/s41579-018-0118-9
Daumas, R. P., Silva, G. A., Tasca, R., Leite, I. D. C., Brasil, P., Greco, D. B., ... & Campos, G. W. D. S. (2020). O papel da atenção primária na rede de atenção à saúde no Brasil: limites e possibilidades no enfrentamento da COVID-19. Cadernos de Saúde Pública, 36, e00104120. https://doi.org/10.1590/0102-311X00104120
Deutsch, A., Ptak, A., Guarascio, F. (2020). Países europeus enfrentam escassez de remdesivir para tratar covid-19. AgênciaBrasil. https://agenciabrasil.ebc.com.br/internacional/noticia/2020-10/paises-europeus-enfrentam-escassez-de-remdesivir-para-tratar-covid-19.
Dong, E., Du, H., & Gardner, L. (2020). An interactive web-based dashboard to track COVID-19 in real time. The Lancet infectious diseases, 20(5), 533-534. https://doi.org/10.1016/S1473-3099(20)30120-1
Du Toit, A. (2020). Outbreak of a novel coronavirus. Nature Reviews Microbiology, 18(3), 123-123. https://doi.org/10.1038/s41579-020-0332-0
Garcia, L. P., & Duarte, E. (2020). Intervenções não farmacológicas para o enfrentamento à epidemia da COVID-19 no Brasil. Epidemiologia e Serviços de Saúde, 29(2), e2020222. https://doi.org/10.5123/S1679-49742020000200009
Garcia, M.; Pinheiro, L. (2021). Anvisa autoriza uso emergencial de coquetel de anticorpos contra Covid-19. https://g1.globo.com/bemestar/coronavirus/noticia/2021/04/20/anvisa-autoriza-uso-emergencial-de-coquetel-contra-covid-19.ghtml.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., & Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
Hulswit, R. J. G., De Haan, C. A. M., & Bosch, B. J. (2016). Coronavirus spike protein and tropism changes. Advances in virus research, 96, 29-57. https://doi.org/10.1016/bs.aivir.2016.08.004
JHU - Johns Hopkins University. 2021. Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE). Johns Hopkins University, 2021. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6/.
Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., & SARS Working Group. (2003). A novel coronavirus associated with severe acute respiratory syndrome. New England journal of medicine, 348(20), 1953-1966. https://doi.org/10.1056/NEJMoa030781
Le, T. T., Andreadakis, Z., Kumar, A., Román, R. G., Tollefsen, S., Saville, M., & Mayhew, S. (2020). The COVID-19 vaccine development landscape. Nature Reviews Drug Discovery, 19(5), 305-306. https://doi.org/10.1038/d41573-020-00073-5
Leme, L. (2021). Veja quais são as vacinas contra covid-19 já aprovadas para aplicação no Brasil. https://www.acidadeon.com/campinas/cotidiano/va cinas/NOT,0,0,1600052,confira-as-vacinas-contra-covid-19-ja-aprovadas-para-aplicacao-no-brasil.aspx.
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., & Feng, Z. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England journal of medicine, 382, 1199-1207. https://doi.org/10.1056/NEJMoa2001316
Lu, H. (2020). Drug treatment options for the 2019-new coronavirus (2019-nCoV). Bioscience trends, 14(1), 69-71. https://doi.org/10.5582/bst.2020.01020
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., ... & Tan, W. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The lancet, 395(10224), 565-574. https://doi.org/10.1016/S0140-6736(20)30251-8
Mackenzie, J. S., & Smith, D. W. (2020). COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don’t. Microbiology Australia, 41(1), 45-50. https://doi.org/10.1071/MA20013
Madabhavi, I., Sarkar, M., & Kadakol, N. (2020). COVID-19: a review. Monaldi Archives for Chest Disease, 90(2), 248-258. https://doi.org/10.4081/monaldi.2020.1298
Nowicki, G. J., Ślusarska, B., Tucholska, K., Naylor, K., Chrzan-Rodak, A., & Niedorys, B. (2020). The severity of traumatic stress associated with COVID-19 pandemic, perception of support, sense of security, and sense of meaning in life among nurses: Research protocol and preliminary results from Poland. International journal of environmental research and public health, 17(18), 6491. https://doi.org/10.3390/ijerph17186491
Pacheco, T. J. A., Souza, D. G. D., Lima, L. I. D., & Longo, J. P. F. (2020). Panorama mundial de estudos com a hidroxicloroquina para o tratamento da COVID-19. Journal of Health & Biological Sciences, 8(1), 1-4. http://dx.doi.org/10.12662/2317-3076jhbs.v8i1.3288.p1-4.2020
Ren, L. L., Wang, Y. M., Wu, Z. Q., Xiang, Z. C., Guo, L., Xu, T., & Wang, J. W. (2020). Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chinese medical journal, 133(9), 1015-1024. http://dx.doi.org/10.1097/CM9.0000000000000722
Shi, Y., Wang, J., Yang, Y., Wang, Z., Wang, G., Hashimoto, K., & Liu, H. (2020). Knowledge and attitudes of medical staff in Chinese psychiatric hospitals regarding COVID-19. Brain, Behavior, & Immunity-Health, 4, 100064. https://doi.org/10.1016/j.bbih.2020.100064
Singhal, T. (2020). A review of coronavirus disease-2019 (COVID-19). The indian journal of pediatrics, 87(4), 281-286. https://doi.org/10.1007/s12098-020-03263-6
Szcześniak, D., Gładka, A., Misiak, B., Cyran, A., & Rymaszewska, J. (2020). The SARS-CoV-2 and mental health: From biological mechanisms to social consequences. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 104(10), e110046. https://doi.org/10.1016/j.pnpbp.2020.110046
Torres, J. I. da S. L., Araújo, J. L., Vieira, J. A., Souza, C. dos S., Passos, I. N. G., Rocha, L. de M. (2021). Endometriosis, difficulties in early diagnosis and female infertility: A review. Research, Society and Development, 10(6), e6010615661. http://dx.doi.org/10.33448/rsd-v10i6.15661
Triggle, C. R., Bansal, D., Abd Farag, E. A. B., Ding, H., & Sultan, A. A. (2020). COVID-19: learning from lessons to guide treatment and prevention interventions. mSphere Journal, 5(3), e00317-20. https://doi.org/10.1128/mSphere.00317-20
Wang, B., Li, R., Lu, Z., & Huang, Y. (2020b). Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY), 12(7), 6049–6057. https://dx.doi.org/10.18632%2Faging.103000
Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020a). A novel coronavirus outbreak of global health concern. The lancet, 395(10223), 470-473. https://doi.org/10.1016/S0140-6736(20)30185-9
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., & Peng, Z. (2020c). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama, 323(11), 1061-1069. http://jamanetwork.com/article.aspx?doi=10.1001/jama.2020.1585
WHO - World Health Organization. 2020. Rolling updates on coronavirus disease (covid-19). Genebra: World Health Organization. Disponível em: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen/. Acesso em: 04 Jan. 2021.
Woo, P. C., Lau, S. K., Lam, C. S., Lau, C. C., Tsang, A. K., Lau, J. H., & Yuen, K. Y. (2012). Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. Journal of virology, 86(7), 3995-4008. https://dx.doi.org/10.1128%2FJVI.06540-11
Yu, F., Du, L., Ojcius, D. M., Pan, C., & Jiang, S. (2020). Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes and infection, 22(2), 74-79. https://doi.org/10.1016/j.micinf.2020.01.003
Yuki, K., Fujiogi, M., & Koutsogiannaki, S. (2020). COVID-19 pathophysiology: A review. Clinical immunology, 108427. https://doi.org/10.1016/j.clim.2020.108427
Zheng, Z., Peng, F., Xu, B., Zhao, J., Liu, H., Peng, J., & Tang, W. (2020). Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. Journal of Infection, 81(2), e16-e25. https://doi.org/10.1016/j.jinf.2020.04.021
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine, 382, 727-733. https://doi.org/10.1056/NEJMoa2001017
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Gardênia Taveira Santos; Joabe Lima Araújo; Lucas Aires de Sousa; Ionara Nayana Gomes Passos; Julia Augusto Vieira; Hugo Vitor Menezes Cruz; Lindalva de Moura Rocha
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
